ArticleFrontiers in oncology2026
Urodynamic characteristics and clinical significance of detrusor overactivity in early (≤6 months) male urinary incontinence following TURP and RARP: a descriptive analysis of two cohorts.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To describe the urodynamic features of early (≤6 months) male urinary incontinence after transurethral resection of the prostate (TURP) and robot-assisted radical prostatectomy (RARP) as two separate cohorts, and to evaluate the clinical significance of detrusor overactivity (DO) within each group, thereby providing descriptive evidence to support tailored diagnosis and treatment strategies. Methods: A retrospective analysis was conducted using data from patients diagnosed with early (≤6 months) urinary incontinence (UI) after TURP or RARP. Urodynamic parameters, including maximum cystometric capacity (MCC), first desire to void (FD), strong desire to void (SD), bladder compliance (BC), abdominal leak point pressure (ALPP), and the presence of detrusor overactivity (DO), were analyzed within each cohort.Subgroup analyses based on DO status were performed separately for each group. The severity of UI was assessed using the International Consultation on Incontinence Questionnaire-Short Form (ICI-Q-SF). Results: A total of 51 patients in the TURP+UI group and 38 patients in the RARP+UI group were included. The TURP+UI group showed significantly higher MCC [260 (207-301) vs 217 (154.50-274.50) mL, P=0.02] and FD (152.78 ± 57.52 vs 123.95 ± 65.65 mL, P=0.03), and lower ICI-Q-SF scores [10 (6-16) vs 19 (17-20), P<0.00] compared to the RARP+UI group. DO was observed in 27.45% of TURP+UI patients and 39.47% of RARP+UI patients. In both groups, patients with DO exhibited significantly lower MCC, FD, SD, and BC values(P<0.00). In the RARP+UI group, patients with DO also had significantly lower ALPP values [0 (0-44) vs 58 (43-91) cmH2O, P<0.001]. Partial correlation analysis revealed that ICI-Q-SF scores were negatively associated with MCC (r=-0.34, p=0.02) and SD (r=[-0.34, p=0.02) in the TURP+UI group, and with ALPP (r=-0.60, p<0.00) in the RARP +UI group. Conclusion: This study describes the urodynamic characteristics of patients with early (≤6 months) UI following TURP and those with UI after RARP as two separate cohorts. In both groups, the presence of DO was associated with reduced MCC and BC, suggesting that DO is a clinically relevant factor affecting storage-phase function regardless of surgical type. The distinct urodynamic profiles observed between the two cohorts likely reflect differences in underlying pathology and surgical mechanisms. Due to the absence of preoperative urodynamic data, these findings should be interpreted as descriptive phenotypic characterizations rather than comparative evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.